Invest in future innovation
Now is the time to act for a sustainable tomorrow
To leave a sustainable world for future generations, Hanwha is proactively investing in forward–looking technologies and businesses. We believe our breakthrough technologies and businesses will lead future innovation as we focus on convergent technologies such as genetic engineering, biotechnology, biopharmaceuticals and data storage/utilization. We are further researching food and seed gene editing technologies that can relieve food crises and reduce carbon emissions.
Biotechnology (Utilization of genetic engineering, biotechnology, biodata storage)
Hanwha Impact is invested in an American gene therapy development company, 'Tessera Therapeutics,' and expects epoch-making changes in the life science field, especially in the treatment of various diseases. We are also investing in 'Inari Agriculture,' an agtech - a compound word of agriculture and technology-, with the aim of creating a future where we can successfully address both the food and climate crises.
Hanwha Solution is conducting R&D and investment in alternative meat. We invest in 'New Age Meats,' a pork cultured meat development company located in California, USA, and a company that produces artificial meat by extracting stem cells from fish, prepares for the future food business, as well as contributes to carbon emission reduction.